163041-68-7

Usage

Uses

Used in Pharmaceutical Industry:
4-TETRAHYDROPYRANOXY-2-METHOXYBENZALDEHYDE is used as an intermediate in the synthesis of various organic compounds for pharmaceutical applications. Its unique chemical structure contributes to the development of new drugs with potential therapeutic properties.
Used in Fragrance Industry:
4-TETRAHYDROPYRANOXY-2-METHOXYBENZALDEHYDE is used as a fragrance ingredient for its pleasant odor. It is incorporated into perfumes, colognes, and other scented products to enhance their aroma profiles.
Used in Food Industry:
4-TETRAHYDROPYRANOXY-2-METHOXYBENZALDEHYDE is used as a flavoring agent in food products. Its pleasant aroma adds a unique taste and scent to various culinary creations, enhancing the overall sensory experience of the food.
Used in Medicinal Chemistry and Drug Development:
4-TETRAHYDROPYRANOXY-2-METHOXYBENZALDEHYDE is studied for its potential biological activities and therapeutic properties. Researchers are exploring its applications in the development of new drugs and therapies, leveraging its chemical properties to target specific health conditions and improve patient outcomes.

InChI:InChI=1/C13H16O4/c1-15-12-8-11(6-5-10(12)9-14)17-13-4-2-3-7-16-13/h5-6,8-9,13H,2-4,7H2,1H3

Upstream product

• 110-87-2 3,4-dihydro-2H-pyran 
• 18278-34-7 4-hydroxy-2-methoxybenzaldehyde 

Downstream Products

• 163041-70-1 C₂₆H₃₀O₆ 
• 1352443-64-1 (E)-1-(furan-2-yl)-3-(4-hydroxy-2-methoxyphenyl)prop-2-en-1-one 
• 1352443-66-3 (E)-3-(4-hydroxy-2-methoxyphenyl)-1-(thiophen-2-yl)prop-2-en-1-one 
• 1352443-61-8 (E)-3-(4-hydroxy-3-methoxyphenyl)-1-(1H-pyrrol-2-yl)prop-2-en-1-one 
• 34221-41-5 echinatin 
• 1437743-11-7 C₁₆H₁₃FO₃ 
• 1437743-21-9 C₁₆H₁₅NO₃ 
• 1437743-16-2 C₁₈H₁₇NO₄ 
• 675865-18-6 [2-methoxy-4-(tetrahydro-pyran-2-yloxy)-benzyl]-[4-(2-pyrrolidin-1-yl-ethoxy)-phenyl]-amine 

Relevant academic research and scientific papers

AMIDE AND SULFONAMIDE LIGANDS FOR THE ESTROGEN RECEPTOR

The present invention provides estrogen receptor (ER) ligands of structural formula (I) the pharmaceutically acceptable salts, stereoisomers, and prodrugs thereof, and the pharmaceutically acceptable salts of the prodrugs, wherein R1, R2, R3, R4, R5, X, a

Biologically active 1,3-bis-aromatic-prop-2-en-1-ones, 1,3-bis-aromatic-propan-1-ones, and 1,3-bis-aromatic-prop-2-yn-1-ones

The invention relates to the use of 1,3-bis-aromatic-prop-2-en-1-ones (chalcones), 1,3-bis-aromatic-propan-1-ones (dihydrochalcones), and 1,3-bis-aromatic-prop-2-yn-1-ones for the preparation of pharmaceutical compositions for the treatment or prophylaxis of a number of serious diseases including i) conditions relating to harmful effects of inflammatory cytokines, ii) conditions involving infection by Helicobacter species, iii) conditions involving infection by viruses, iv) neoplastic disorders, and v) conditions caused by microorganisms or parasites. The invention also relates to novel chalcones and dihydrochalcones (especially alkoxy substituted variants) having advantageous substitution patterns with respect to their effect as drug substances, and to methods of preparing them, as well as to pharmaceutical compositions comprising the novel chalcones. Moreover, the present invention relates to a method for the isolation of Leishmania fumarate reductase, QSAR methodologies for selecting potent compounds for the above-mentioned purposes.